Structural determinants of phosphodiesterase 6 response on binding catalytic site inhibitors

Neurochemistry International

Volumn 49, Issue 3, 2006, Pages 215-222

  Simon, Ágnes ^a   Barabás, Péter ^a   Kardos, Julianna ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Docking; Electric light response; Retina; Sildenafil; Type 5 and 6 phosphodiesterases; Zaprinast

Indexed keywords

GUANOSINE PHOSPHATE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 6; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CATALYSIS; CONFORMATION; ENZYME BINDING; ENZYME STRUCTURE; NONHUMAN; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; RAT; RETINA;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATALYTIC DOMAIN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN STRUCTURE, SECONDARY; RATS; RATS, WISTAR; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33745643544     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.01.011     Document Type: Article

References (50)

1. Ames III A., Walseth T.F., Heyman R.A., Barad M., Graeff R.M., and Goldberg N.D. Light-induced increases in cGMP metabolic flux correspond with electrical responses of photoreceptors. J. Biol. Chem. 261 (1986) 13034-13042
2. Barabás P., Kovács I., Kovács R., Pálhalmi J., Kardos J., and Schusboe A. Light-induced changes in glutamate release from isolated rat retina is regulated by cyclic guanosine monophosphate. J. Neurosci. Res. 67 (2002) 149-155
3. Barabás P., Riedl Zs., and Kardos J. Sildenafil, N-desmethyl-sildenafil and zaprinast enhance photoreceptor response in the isolated rat retina. Neurochem. Int. 43 (2003) 591-595
4. Barabás P., Antal K., and Kardos J. Light-adaptation attenuates the effects of phosphodiesterase blockade by zaprinast in the isolated rat retina. Neurosci. Lett. 357 (2004) 195-198
5. Baylor D.A., Lamb T.D., and Yau K.W. Responses of retinal rods to single photons. J. Physiol. 288 (1979) 613-634
6. Baylor D. How photons start vision. Proc. Natl. Acad. Sci. U.S.A. 93 2 (1996) 560-565
7. Capovilla M., Cervetto L., and Torre V. Antagonism between steady light and phosphodiesterase inhibitors on the kinetics of rod photoresponses. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 6698-6702
8. Capovilla M., Cervetto L., and Torre V. The effect of phosphodiesterase inhibitors on the electrical activity of toad rods. J. Physiol. 343 (1983) 277-294
9. Cobbs W.H. Light and dark active phosphodiesterase regulation in salamander rods. J. Gen. Physiol. 98 (1991) 575-614
10. Choi G., Landin J., Galan J.F., Birge R.R., Albert A.D., and Yeagle P.L. Structural studies of metarhodopsin II, the activated form of the G-protein coupled receptor, rhodopsin. Biochemistry 41 (2002) 7318-7324
11. Copenhagen D.R., and Jahr C.E. Release of endogenous excitatory amino acids from turtle photoreceptors. Nature 341 (1989) 536-539
12. Corbin J.D., Beasley A., Blount M.A., and Francis S.H. Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5). Neurochem. Int. 45 (2004) 859-863
13. Corbin J.D., and Francis S.H. Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem. 274 (1999) 13729-13732
14. Cornwall M.C., Fein Jr. A., and MacNichol E.F. Cellular mechanisms that underlie bleaching and background adaptation. J. Gen. Physiol. 96 (1990) 345-372
15. Cote R.H. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5. Int. J. Impot. Res. 16 (2004) S28-S33
16. D'amours M.R., Granovsky A.E., Artemyev N.O., and Cote R.H. Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme. Mol. Pharmacol. 3 (1999) 508-514
17. Dinsmore W.W. Available and future treatments for erectile dysfunction. Clin. Cornerstone 7 (2005) 37-45
18. Francis S.H., Bessay E.P., Kotera J., Grimes K.A., Liu L., Thompson W.J., and Corbin J.D. Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity. J. Biol. Chem. 277 (2002) 47581-47587
19. Granovsky A.E., and Artemyev N.O. A conformational switch in the inhibitory gamma-subunit of PDE6 upon enzyme activation by transducin. Biochemistry 40 (2001) 13209-13215
20. Granovsky A.E., and Artemyev N.O. Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5. J. Biol. Chem. 276 (2001) 21698-21703
21. Granovsky A.E., Natochin M., and Artemyev N.O. The gamma subunit of rod cGMP-phosphodiesterase blocks the enzyme catalytic site. J. Biol. Chem. 272 (1997) 11686-11689
22. Granovsky A.E., Natochin M., McEntaffer R.L., Haik T.L., Francis S.H., Corbin J.D., and Artemyev N.O. Probing domain functions of chimeric PDE6alpha'/PDE5 cGMP-phosphodiesterase. J. Biol. Chem. 273 (1998) 24485-24490
23. Gupta M., Kovar A., and Meibohm B. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction. J. Clin. Pharmacol. 45 (2005) 987-1003
24. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2713-2714
25. Hamilton S.E., Prusti R.K., Bentley J.K., Beavo J.A., and Hurley J.B. Affinities of bovine photoreceptor cGMP phosphodiesterases for rod and cone inhibitory subunits. FEBS Lett. 318 (1993) 157-161
26. Kajimura N., Yamazaki M., Morikawa K., Yamazaki A., and Mayanagi K. Three-dimensional structure of non-activated cGMP phosphodiesterase 6 and comparison of its image with those of activated forms. J. Struct. Biol. 139 1 (2002) 27-38
27. Kameni Tcheudji J.F., Lebeau L., Virmaux N., Maftei C.G., Cote R.H., Lugnier C., and Schultz P. Molecular organization of bovine rod cGMP-phosphodiesterase 6. J. Mol. Biol. 310 (2001) 781-791
28. Kaupp U.B., and Seifert R. Cyclic nucleotide-gated ion channels. Physiol. Rev. 82 (2002) 769-824
29. Krier M., de Araujo-Junior J.X., Schmitt M., Duranton J., Justiano-Basaran H., Lugnier C., Bourguignon J.-J., and Rognan D. Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold: application to the structure-based optimization of phosphodiesterase 4 inhibitor. J. Med. Chem. 48 (2005) 3816-3822
30. Laties A.M., and Zrenner E. Viagra (sildenafil citrate) and ophthalmology. Prog. Retina Eye Res. 21 (2002) 485-506
31. Lyubarsky A., Nikonov Jr. S., and Pugh E.N. The kinetics of inactivation of the rod phototransduction cascade with constant Ca2 + i. J. Gen. Physiol. 107 (1996) 19-34
32. Luu J.K., Chappelow A.V., McCulley T.J., and Marmor M.F. Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am. J. Ophthalmol. 132 (2001) 388-394
33. Manallack D.T., Hughes R.A., and Thompson P.E. The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases. J. Med. Chem. 48 (2005) 3449-3462
34. Mehats C., Andersen C.B., Filopanti M., Jin S.L., and Conti M. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signalling. Trends Endocrinol. Metab. 13 (2002) 29-35
35. Mou H., and Cote R.H. The catalytic and GAF domains of the rod cGMP phosphodiesterase (PDE6) heterodimer are regulated by distinct regions of its inhibitory gamma subunit. J. Biol. Chem. 276 (2001) 27527-27534
36. Navarra M., Baltrons M.A., Sardon T., Pedraza C.E., and Garcia A. HIV-1 coat protein gp120 decreases NO-dependent cyclic GMP accumulation in rat brain astroglia by increasing cyclic GMP phosphodiesterase activity. Neurochem. Int. 45 (2004) 937-946
37. Norton A.W., D'Amours M.R., Grazio H.J., Hebert T.L., and Cote R.H. Mechanism of transducin activation of frog photoreceptor phosphodiesterase. J. Biol. Chem. 275 (2000) 28611-28619
38. Prickaerts J., Sik A., van Staveren W.C., Koopmans G., Steinbusch H.W., van der Staay F.J., de Vente J., and Blokland A. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem. Int. 45 (2004) 915-928
39. Shin D., Heo Y.S., Lee K.J., Kim C.M., Yoon J.M., Lee J.I., Hyun Y.L., Jeon Y.H., Lee T.G., Cho J.M., and Ro S. Structural chemoproteomics and drug discovery. Biopolymers 80 (2005) 258-263
40. Sung B.J., Hwang K.Y., Jeon Y.H., Lee J.I., Heo Y.S., Kim J.H., Moon J., Yoon J.M., Hyun Y.L., Kim E., Eum S.J., Park S.Y., Lee J.O., Lee T.G., Ro S., and Cho J.M. Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature 425 (2003) 98-102
41. Szabó-Salfay O., Pálhalmi J., Szatmári E., Barabás P., Szilágyi N., and Juhász G. The electroretinogram and visual evoked potential of freely moving rats. Brain Res. Bull. 56 (2001) 7-14
42. Turko I.V., Ballard S.A., Francis S.H., and Corbin J.D. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds. Mol. Pharmacol. 56 (1999) 124-130
43. White J.B., Thompson W.J., and Pittler S.J. Characterization of 3′,5′ cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6. Mol. Vis. 10 (2004) 738-749
44. Witkowsky, P., Thoreson, W., Tranchina, D., 2001. Transmission at the photoreceptor synapse. In: Kolb, H., Ripps, H., Wu, S. (Eds.), Concepts and Challenges in Retinal Biology, vol. 131, Progress in Brain Research, Elsevier, Netherlands, pp. 145 (Chapter 9).
45. Yeagle P.L., and Albert A.D. A conformational trigger for activation of a G protein by a G protein-coupled receptor. Biochemistry 42 (2003) 1365-1368
46. 2+ on signal transmission from rods and cones to bipolar cells in carp retina. Brain Res. 957 (2002) 136-143
47. Xu R.X., Hassell A.M., Vanderwall D., Lambert M.H., Holmes W.D., Luther M.A., Rocque W.J., Milburn M.V., Zhao Y., Ke H., and Nolte R.T. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science 288 (2000) 1822-1825
48. Yeon Y.H., Heo Y.-S., Kim C.M., Hyun Y.-L., Lee T.G., Ro S., and Cho J.M. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell. Mol. Life Sci. 62 (2005) 1198-1220
49. Zhang K.Y., Card G.L., Suzuki Y., Artis D.R., Fong D., Gillette S., Hsieh D., Neiman J., West B.L., Zhang C., Milburn M.V., Kim S.-H., Schlessinger J., and Bollag G. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases. Mol. Cell 15 (2004) 279-286
50. Zhang X., Feng Q., and Cote R.H. Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors. Invest. Ophthalmol. Visual Sci. 46 (2005) 3060-3066